TAMMI HUDSPETH: Open Payments
NPI 1992781678 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 26 payments from 12 companies in 2025. Trend: 2023 $1,954 · 2024 $1,089 · 2025 $976
Food & beverage: $965Education: $11
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $179 |
| Actelion Pharmaceuticals US, Inc. | 1 | $150 |
| Merck Sharp & Dohme LLC | 2 | $136 |
| E.R. Squibb & Sons, L.L.C. | 4 | $108 |
| American Regent | 1 | $87 |
| United Therapeutics Corporation | 3 | $83 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $75 |
| AstraZeneca Pharmaceuticals LP | 1 | $65 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
Products named: CARDIOMEMS, UPTRAVI, WINREVAIR, INJECTAFER, CAMZYOS, REMODULIN, LifeVest, WAINUA.
Industry payments across WA — which companies pay providers there.
